1. Molecular subtypes of bladder cancer;McConkey;Curr Oncol Rep,2018
2. Treatment of muscle-invasive and advanced bladder cancer in 2020;Patel;CA Cancer J Clin,2020
3. EV-302/KEYNOTE-A39: open-label,randomized phase III study of enfortumab vedotin in combination with pembrolizumab(EV+P) vs chemotherapy(chemo) in previously untreated locally advanced metastatic urothelial carcinoma(la/mUC);Powles;Ann. Oncol.,2023
4. Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma;Powles;N Engl J Med,2020
5. Nivolumab plus gemcitabine-cisplatin in advanced urothelial carcinoma;van der Heijden;N Engl J Med,2023